Recent Company News

• 10:06 AM ET Aug 19, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (74 total)

• 07:34 AM ET Aug 13, 2025
  

  Brainsway reports Q2 EPS $0.05 vs FactSet $0.03 [4 est, $0.02-0.05] ($12.19, 0.00)

• 10:09 AM ET Jul 07, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (148 total)

• 10:11 AM ET Jun 30, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (130 total)

• 10:07 AM ET Jun 27, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (101 total)

• 10:08 AM ET Jun 26, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (102 total)

• 11:20 AM ET Jun 24, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (142 total)

• 10:15 AM ET Jun 11, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (64 total)

• 07:32 AM ET Jun 11, 2025
  

  BrainsWay reports results from multicenter randomized study of accelerated deep TMS for major depressive disorder (MDD) ($11.46, 0.00)

• 07:31 AM ET Jun 04, 2025
  

  Brainsway announces $5M minority-stake investment in Stella MSO, LLC ($10.19, 0.00)